In cancer therapy and vaccines, Kavitha Yaddanapudi and Shuhan Meng group demonstrated that ESC-derived exosomes genetically engineered to overexpress granulocyte-macrophage colony-stimulating factor (GM-CSF) function as cell-free vesicles to boost immune responses against tumors [189–191]. The gene discussed is CSF2; the disease is cancer.